Jun 29, 2025, 13:46
Molecular Upgrade: 2025 Hemophilia Care Hits Next Level
William McKeown recently posted on X:
”Beautiful slide from Maria Elisa Mancuso summarising the molecules which can be used to treat Hemophilia at the European Haemophilia Consortium Leadership Conference.”
Haemophilia management is advancing so rapidly, it’s as if the disease is preparing for early retirement!
The EHC Leadership Conference is in full swing.
From antibodies to gene therapy, Maria Elisa Mancuso took the stage to present an exciting spectrum of treatment strategies set for 2025.
More updates on Hemophilia with Hemostasis Today.
-
Nov 10, 2025, 10:16Pablo Corral on Enlicitide: The Phase 3 CORALreef HeFH Trial Brings a Major Step Forward
-
Nov 10, 2025, 10:15Laurent Bertoletti Invites You to the Joint INNOVTE and GITA Meeting on Hormones and Thrombosis
-
Nov 10, 2025, 10:15Christopher Cannon: DOAC Monotherapy Wins Again
-
Nov 10, 2025, 10:14Marieke Kruip on Sex differences in Outcomes of VKA Treatment in Patients with Mechanical Heart Valve
-
Nov 10, 2025, 10:14Ana Paula Lacombe: From Research to Bedside, Innovation in Stroke Care is Moving Fast!
-
Nov 10, 2025, 10:13Jan Sloves: Understanding Iliofemoral DVT – What You Can’t Afford to Miss
-
Nov 10, 2025, 10:12Mohamed Rawy Shares a Comprehensive Guide For Anticoagulation
-
Nov 10, 2025, 10:10Marc Carrier: Proud to Share the Results of the WAVe Study
-
Nov 10, 2025, 10:07Frederik Denorme – The New PI at the Laboratory of Cell Biology and Histology at University of Antwerp